Quetiapine Fumarate
Product Images NDC 50090-3198

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 50090-3198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl500903198)

Label Image (Lbl500903198)
Label for QUETIAPINE FUMARATE 300 MG extended release tablets by A-S Medication Solutions. The package contains 60 tablets with once daily dosing and storage instructions to keep the tablets at 68 to 77 degrees Fahrenheit. The label includes the product NDC 50090-3198-0 and specifies that each tablet contains 300 mg of quetiapine fumarate.*
FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Figure 1)

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Figure 1)
A Kaplan-Meier survival curve showing the proportion of patients with relapse (%) over time (months) comparing two groups: PLA (placebo) represented by a dashed line and QTP XR (quetiapine extended-release) represented by a solid line. The y-axis ranges from 0 to 100%, and the x-axis ranges from 0 to 7 months.*
FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Figure 2)

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Figure 2)
A line graph comparing the proportion of patients with relapse (%) over time (weeks) between two groups: QTP+ LI/VAL and PLA+ LI/VAL. The graph shows relapse rates increasing over approximately 100 weeks, with the PLA+ LI/VAL group having a higher relapse proportion compared to the QTP+ LI/VAL group.*
FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Figure 3)

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Figure 3)
A line graph depicting the proportion of patients with relapse (%) over time (weeks) for two groups: QTP+LIVAL and PLA+LIVAL. The graph shows relapse rates on the y-axis and time in weeks on the x-axis, with QTP+LIVAL represented by a dashed line and PLA+LIVAL by a solid line.*
FDA Label Image

Structural Formula (Quetiapine Structure)

Structural Formula (Quetiapine Structure)
Chemical structure diagram of quetiapine fumarate, showing the quetiapine molecule associated with fumarate ions in a 2:1 ratio.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.